Sign in

Trial result ·

A Composite Ovine Forestomach Matrix and Hyaluronic Acid CAMP for the Treatment of Full Thickness Wounds of the Foot in People With Diabetes: A Randomized Controlled Trial.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This study looked at foot wounds in people with diabetes. The wounds were long-lasting and went through the full skin. The team tested a wound cover called OFM-HA. It is made from sheep stomach tissue and hyaluronic acid. In this trial, 143 people were put into groups by chance. One group got OFM-HA plus usual wound care. The other group got usual wound care alone. The trial took place at several centres.

What they found

The main goal was to see how many wounds healed by 12 weeks. In the OFM-HA group, 31 of 68 wounds healed by then. In the usual care group, 17 of 72 wounds healed. This gap was unlikely to be due to chance alone. Over the 12 weeks, the pace of healing also favoured OFM-HA. No unexpected safety problems were seen.

What it means for patients

The authors say OFM-HA plus usual care raised wound closure at 12 weeks. They note this result was in a selected group of people. Only people who met the trial's entry rules took part.

Why it is not certain yet

The authors list several limits. Some people were removed from the study after the groups were set. People also left the groups at different rates. A second, adjusted test was only just past the usual cutoff. The abstract does not give results for pain or quality of life. The abstract gives no results past 12 weeks.

Source

A Composite Ovine Forestomach Matrix and Hyaluronic Acid CAMP for the Treatment of Full Thickness Wounds of the Foot in People With Diabetes: A Randomized Controlled Trial.

PubMed · PMID 42823610

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Diabetic foot ulcer publications